Academic Journal
Q2Scandinavian Journal of Rheumatology
About Scandinavian Journal of Rheumatology
About Scandinavian Journal of Rheumatology
Scandinavian Journal of Rheumatology is a peer-reviewed scholarly journal published by 209 (United Kingdom). It focuses on Q2. Publication coverage spans 1959-1962, 1964, 1972-2026.
Key indicators: ISSN 1502-7732, 0300-9742; H-index 90.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (90): Strong citation impact — 90 articles cited at least 90 times each, reflecting solid influence.
Publishing in Scandinavian Journal of Rheumatology
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q2. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Scandinavian Journal of Rheumatology?
1502-7732, 0300-9742.
Who publishes Scandinavian Journal of Rheumatology?
209.
What are Scandinavian Journal of Rheumatology's metrics?
H-index 90.
Is Scandinavian Journal of Rheumatology peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Rheumatoid Arthritis Research and Therapies; Systemic Lupus Erythematosus Research; Spondyloarthritis Studies and Treatments; Systemic Sclerosis and Related Diseases; Autoimmune and Inflammatory Disorders Research; Monoclonal and Polyclonal Antibodies Research.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Diagnostic utility of the HAS-GCA score versus other Southend Giant Cell Arteritis Probability Score–ultrasound prediction models in giant cell arteritis
H Wulff Schjødt Stoklund, IT Tønder Hansen, KK Keller, P Therkildsen et al.
2026-10-09 · DOI: 10.1080/03009742.2026.2724672Effectiveness of interleukin (IL)-23 and IL-12/23 inhibitors and factors associated with response in psoriatic arthritis with axial involvement: the APxis-IL12-23 study
R Almodóvar, R Mazzucchelli, E Pérez-Fernández, E Trujillo et al.
2026-10-09 · DOI: 10.1080/03009742.2026.2730765Colchicine for hypergammaglobulinaemic purpura of Waldenström in Sjögren’s disease: a case series
MB Thaler, FTH Ullrich, D Gailis, T Sonneck et al.
2026-10-09 · DOI: 10.1080/03009742.2026.2727250Cardiovascular risk and all-cause mortality across low-density lipoprotein cholesterol levels in seropositive rheumatoid arthritis: a nationwide cohort study
JH Choi, JS Lee, C-N Son, B Ghang et al.
2026-10-01 · DOI: 10.1080/03009742.2026.2711548Efficacy and safety of tofacitinib in polymyalgia rheumatica: a retrospective comparative study
X Wang, D Feng, L Jia, L Xu et al.
2026-09-16 · DOI: 10.1080/03009742.2026.2722526Risk of peripheral artery disease following ankylosing spondylitis, 2012–2023: a nationwide cohort study in South Korea
Y Bae, M Jang, K-Y Bak, SR Jeon et al.
2026-09-16 · DOI: 10.1080/03009742.2026.2722472Prevalence of severe functional limitations and physical therapy use in patients with rheumatoid arthritis or axial spondyloarthritis: a multicentre cross-sectional study in the Netherlands
AR Iken, L van Bodegom-Vos, TPM Vliet Vlieland, FA van Gaalen et al.
2026-09-08 · DOI: 10.1080/03009742.2026.2711489iPhone Compass for cervical rotation in ankylosing spondylitis: are we ready for clinical translation?
B Choudhuri
2026-09-01 · DOI: 10.1080/03009742.2026.2719330Marked neurological recovery after severe Takayasu arteritis-associated cerebral infarction without revascularization: a case report
K Izaki, M Fujimura, H Hara, R Tsutsumi et al.
2026-09-03 · DOI: 10.1080/03009742.2026.2712802Factors associated with shorter time to death and causes of mortality among deceased patients with systemic sclerosis: a multicentre retrospective study
MA Balcı, Z Yağbasan, İ Gunduz, AN Bayindir Akbaş et al.
2026-08-20 · DOI: 10.1080/03009742.2026.2700105Induction of type I and III interferons by viral and endogenous stimuli in systemic sclerosis
S Adeli, ÖI Emilsson, E Hellbacher, K Hjorton et al.
2026-08-18 · DOI: 10.1080/03009742.2026.2711485A self-management app in a digital treat-to-target gout-care approach: the ReMonit Gout feasibility study
J Stjärne, F Aanesen, S Søhus, A Abhishek et al.
2026-08-13 · DOI: 10.1080/03009742.2026.2706265Response to the letter regarding ‘Assessing cervical rotation in ankylosing spondylitis: iPhone Compass versus traditional tools’
G Kenar Artin, H Yarkan Tugsal, B Akin, P Cetin et al.
2026-08-12 · DOI: 10.1080/03009742.2026.2706269Patterns of migration underlie the increasing incidence of Kawasaki disease in Sweden from 1987 to 2018: a cohort study
A Rudolph, J Mofors, A Frisk, B Schiller et al.
2026-07-15 · DOI: 10.1080/03009742.2026.2658353Large-vessel vasculitis with mediastinitis after acupuncture: a case report
K Naito, H Yorifuji, Y Katada, M Naito et al.
2026-07-08 · DOI: 10.1080/03009742.2026.2692304Distinct clinical outcomes of positron emission tomography/computed tomography-based subtypes in treatment-naïve Takayasu arteritis
T Katakura, T Shirai, Y Ishii, H Sato et al.
2026-07-03 · DOI: 10.1080/03009742.2026.2677340Sámi psoriatic arthritis patients in northern Norway receive less conventional synthetic disease-modifying anti-rheumatic drug treatment and have more arthritis, axial symptoms, and joint damage
N Panagiotopoulos, MI Rosic, AR Broderstad, G Haugeberg et al.
2026-07-03 · DOI: 10.1080/03009742.2026.2687239Elevated serum immunoglobulin A predicts extra-articular manifestations in axial spondyloarthritis
A Pistone, M Soyfoo, L Tant
2026-07-01 · DOI: 10.1080/03009742.2026.2677298Multimodal imaging in the diagnosis of iliopsoas bursitis complicating biological therapy in rheumatoid arthritis: a case report with therapeutic implications
ÜC Ateş, S Gülle, C Koçak Ateş
2026-06-30 · DOI: 10.1080/03009742.2026.2690725Cervical spine instability in axial spondyloarthritis: prevalence, patterns, and predictive factors in a high-risk cohort
S Ketenci, A Kababıyık, H Oğuzman, M Pekdiker et al.
2026-06-19 · DOI: 10.1080/03009742.2026.2674341Reviews
Community Reviews
Version History
October 10, 2026 at 1:19 am
October 2, 2026